Evidence map›Paper›PMID 35044104›Full record

ArticleThoracic cancer2022

Circ_0007580 knockdown strengthens the radiosensitivity of non-small cell lung cancer via the miR-598-dependent regulation of THBS2.

Zheng Yang, Hongfang Wu, Kai Zhang, Shilei Rao, Shuran Qi, Manxiang Liu, Ying Chen, Yang Wang

Abstract read
In one paragraph

Article in Thoracic cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zheng YangDepartment of Radiotherapy, Nanyang Central Hospital, Nanyang, China.
Hongfang WuDepartment of Pathology, Department of Basic Medicine, Nanyang Medical College, Nanyang, China.
Kai ZhangDepartment of Radiotherapy, Nanyang Central Hospital, Nanyang, China.ORCID 0000-0002-0087-9081
Shilei RaoDepartment of Radiotherapy, Nanyang Central Hospital, Nanyang, China.
Shuran QiDepartment of Radiotherapy, Nanyang Central Hospital, Nanyang, China.
Manxiang LiuDepartment of Radiotherapy, Nanyang Central Hospital, Nanyang, China.
Ying ChenDepartment of Nursing, Nanyang Medical College, Nanyang, China.
Yang WangDepartment of Radiotherapy, Nanyang Central Hospital, Nanyang, China.ORCID 0000-0002-8576-9569

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRadioresistance is a common cause of treatment failure in many cancers, including non-small cell lung cancer (NSCLC). Circular RNA (circRNA) has been shown to be involved in the radiosensitivity of many cancers. However, the role and mechanism of circ_0007580 in the radiosensitivity of NSCLC remain unclear.

methodsThe expression levels of circ_0007580, miR-598 and thrombospondin 2 (THBS2) were estimated by quantitative real-time PCR. The radiosensitivity of cells was measured using colony formation assay. Cell proliferation and apoptosis were assessed by performing cell counting kit 8 assay, colony formation assay, flow cytometry, and by detecting caspase-3 and caspase-9 activities. Protein expression was determined using western blot analysis.

resultsOur data showed that circ_0007580 was highly expressed and miR-598 was lowly expressed in radioresistant NSCLC tissues. Functional experiments suggested that circ_0007580 silencing could improve the radiosensitivity of cells by suppressing cell proliferation and increasing apoptosis. MiR-598 was confirmed to be a target of circ_0007580, and its inhibitor could reverse the regulation of circ_0007580 on the radiosensitivity of NSCLC cells. MiR-598 was found to target THBS2. The suppressive effect of miR-598 on the radiosensitivity of cells could be reversed by THBS2 overexpression. Additionally, circ_0007580 could sponge miR-598 to regulate THBS2. In vivo experiments showed that knockdown of circ_0007580 enhanced the radiosensitivity of NSCLC tumors.

conclusionsOur results revealed that circ_0007580 might be a target for improving the radiosensitivity of NSCLC, which was mainly achieved by regulating the miR-598/THBS2 axis.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsMicroRNAsRNA, CircularCell Line, TumorCell ProliferationHumansRadiation ToleranceThrombospondin 2ThrombospondinsMicroRNAsMIRN-598 microRNA, humanRNA, CircularThrombospondin 2Thrombospondinscirc_0007580miR-598non-small cell lung cancerTHBS2

Identifiers

PMID35044104
PMCPMC8888153

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.